Filing Details
- Accession Number:
- 0001140361-12-025597
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-15 20:19:42
- Reporting Period:
- 2012-05-13
- Filing Date:
- 2012-05-15
- Accepted Time:
- 2012-05-15 19:19:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1033905 | Luminex Corp | LMNX | Surgical & Medical Instruments & Apparatus (3841) | 742747608 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238407 | T Harriss Currie | 12212 Technology Boulevard Austin TX 78727 | Vp Finance & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-05-13 | 660 | $23.80 | 122,454 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2012-05-14 | 20,000 | $6.52 | 142,454 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-05-14 | 20,000 | $23.52 | 122,454 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | STOCK OPTION (RIGHT TO BUY) | Disposition | 2012-05-13 | 20,000 | $0.00 | 20,000 | $6.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-05-23 | 2012-05-23 | No | 4 | M | Direct |
Footnotes
- This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1 adopted by the seller on August 24, 2011. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the aforementioned trading plan was adopted.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.31 to $23.76 inclusive. Mr. Currie undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.
- The option vested in one installment on May 23, 2005.